Heart Disease News and Research

Latest Heart Disease News and Research

Lipoic acid appears to slow down the process of aging

Researchers have identified the mechanism of action of lipoic acid, a remarkable compound that in animal experiments appears to slow down the process of aging, improve blood flow, enhance immune function and perform many other functions.

18 May 2007

Effects of Taser on human health

Using a Taser to control agitated suspects in police custody is standard operating procedure for many law enforcement agencies.

18 May 2007

Not enough is known about long-term safety of "functional foods"

So-called 'functional foods' need to be systematically monitored because not enough is known about their long-term safety and effectiveness, say a group of scientists writing in the British Medical Journal.

18 May 2007

Some NSAIDs may be better suited to treating cancer

Until recently, nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin and celecoxib (sold as Celebrex), were being hailed as promising cancer prevention drugs.

18 May 2007

Stroke prevalence varies across U.S.

Stroke prevalence varies widely from state to state, with some states and U.S. territories having more than double the stroke prevalence of others, according to a new report from the Centers for Disease Control and Prevention (CDC).

18 May 2007

One kilogram higher birth weight associated with a 10-20% reduced risk of heart disease later in life

Dr Rachel Huxley, lead author of the paper and Acting Director of Nutrition and Lifestyle at The George Institute said, "Although there was support for a small association between birth weight and an individual's future risk of heart disease, the relationship is not as strong as earlier studies have suggested.

18 May 2007

Link between extreme sleep disorder and onset of parkinsonism or dementia

Mayo Clinic researchers and a group of international collaborators have discovered a correlation between an extreme form of sleep disorder and eventual onset of parkinsonism or dementia.

17 May 2007

Novel device helps monitor mental illness

Psychiatric researchers at the University of California, San Diego (UCSD) School of Medicine will report important new findings from a study of patients with bipolar affective disorder and schizophrenia at the upcoming meeting of the Society of Biological Psychiatry, to be held in San Diego May 17-20.

17 May 2007

Ottawa Aggressive Protocol for acute atrial fibrillation is successful

There is no consensus on Emergency Department management of acute atrial fibrillation (AAF) or atrial flutter (AAFL).

17 May 2007

Pycnogenol natural pine bark extract reduces heart failure

A study to be published in an upcoming edition of the journal of Cardiovascular Toxicology reveals Pycnogenol natural pine bark extract from the French maritime pine tree, helps prevent damage that high blood pressure causes to the heart.

17 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

New guidelines for blood conservation during cardiac procedures

A team of medical experts led by a Virginia Commonwealth University anesthesiologist and a thoracic surgeon from the University of Kentucky has established a set of clinical guidelines to help physicians decrease the need for blood transfusions in high-risk patients during cardiac operations.

17 May 2007

Virtual Iraq provides better understanding of post-traumatic stress disorder

Weill Cornell Medical College researchers are using a virtual reality simulation called "Virtual Iraq" to better understand how symptoms of post-traumatic stress disorder (PTSD) develop.

17 May 2007

Project aims to develop stem cell lines that genetically match human patients

These lines would allow scientists to better study conditions ranging from diabetes to Parkinson's disease, and they would provide the basis for potential patient-specific stem cell treatments.

17 May 2007

Minimally invasive treatment of chronic mesenteric ischemia

Using catheter techniques perfected in the arteries of the heart, interventional cardiologists are successfully treating chronic mesenteric ischemia, a condition akin to intestinal angina.

17 May 2007

Unfair treatment in life boosts a person's chances of having a heart attack

The findings are based on more than 8,000 senior civil servants working for the British government in London (The Whitehall Study II).

16 May 2007

Women are significantly less likely than men to have their LDL cholesterol controlled

The study, to be published in the May/June edition of Women's Health Issues, investigated gender differences in cardiovascular disease prevention, treatment and risk factors based on national health care quality data from commercial and Medicare managed care plans.

16 May 2007

Reducing cardiovascular disease risk factors when discontinuing HRT

Hormone replacement therapy (HRT) has been shown to reduce many cardiovascular disease (CVD) risk factors, but many women have stopped using HRT due to reports from the Women's Health Initiative that HRT may increase the risk of breast cancer and heart disease.

16 May 2007

Potential therapeutic target for autoimmune vasculitis

A potential therapeutic target for autoimmune vasculitis has been identified by researchers of the Franz Volhard Clinic for Cardiovascular Diseases (FVK) of the Charity – University Medicine Berlin/HELIOS-Klinikum and the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch.

16 May 2007

Cronic obstructive pulmonary disease is a major and increasing global health epidemic

Cronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world's leading experts on lung disease.

16 May 2007